Enzymatic Synthesis of Ascorbic Acid-Ketone Body Hybrids

Molecular hybrids obtained by connecting two or more bioactive molecules through a metabolizable linker are used as multi-target drugs for the therapy of multifactorial diseases. Ascorbic acid, as well as the ketone bodies acetoacetate and (R)-3-hydroxybutyrate, are bioactive molecules that have common fields of application in the treatment and prevention of neurodegenerative diseases and cardiac injuries as well. In spite of this, the preparation of ascorbic acid ketone body hybrids is uncovered by the literature. Herein, we report the lipase-catalyzed condensation of methyl acetoacetate with ascorbic acid, which affords the 6-O-acetoacetyl ascorbic acid in quantitative yield. The same approach, employing the methyl (R)-3-hydroxybutyrate in place of the methyl acetoacetate, allows the preparation of the 6-O-(R)-3-hydroxybutyryl ascorbic acid in 57% yield. A better result (90% overall yield) is achieved through the lipase-catalyzed coupling of ascorbic acid with methyl (R)-3-O-methoxymethyl-3-hydroxybutyrate followed by the cleavage of the MOM protecting group. The two novel products are fully characterized and additional information on the antioxidant activity of the new products is also given.

[1]  R. Rizzo,et al.  The Evolution of Ketosis: Potential Impact on Clinical Conditions , 2022, Nutrients.

[2]  J. Nasser,et al.  The Implication of Physiological Ketosis on The Cognitive Brain: A Narrative Review , 2022, Nutrients.

[3]  C. Johansson,et al.  Editorial: Novel Strategies in Drug Development Against Multifactorial Diseases , 2022, Frontiers in Chemistry.

[4]  V. Ahluwalia,et al.  Synthesis of food-grade 6-O-ascorbyl fatty esters and their semi-synthesis from low-value oils as resources , 2021, Biomass Conversion and Biorefinery.

[5]  A. Cavazzini,et al.  Nutrient Composition and Antioxidant Performances of Bread-Making Products Enriched with Stinging Nettle (Urtica dioica) Leaves , 2021, Foods.

[6]  A. Dhingra,et al.  Natural products: A lead for drug discovery and development , 2021, Phytotherapy research : PTR.

[7]  G. Lopaschuk,et al.  KETONE METABOLISM IN THE FAILING HEART. , 2020, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[8]  A. Capriotti,et al.  Peptidomic Approach for the Identification of Peptides with Potential Antioxidant and Anti-Hyperthensive Effects Derived From Asparagus By-Products , 2019, Molecules.

[9]  S. Raić-Malić,et al.  Therapeutic Perspective of Vitamin C and Its Derivatives , 2019, Antioxidants.

[10]  J. Bäckvall,et al.  Transesterification of a Tertiary Alcohol by Engineered Candida antarctica Lipase A , 2019, Chembiochem : a European journal of chemical biology.

[11]  O. Barbosa,et al.  Novozym 435: the “perfect” lipase immobilized biocatalyst? , 2019, Catalysis Science & Technology.

[12]  S. Juul,et al.  Exogenous Ketone Bodies as Promising Neuroprotective Agents for Developmental Brain Injury , 2019, Developmental Neuroscience.

[13]  G. Bérubé.  An overview of molecular hybrids in drug discovery , 2016, Expert opinion on drug discovery.

[14]  M. Carević,et al.  Influence of fatty acid on lipase‐catalyzed synthesis of ascorbyl esters and their free radical scavenging capacity , 2015, Biotechnology and applied biochemistry.

[15]  G. Salido,et al.  Evaluation of the antiaggregant activity of ascorbyl phenolic esters with antioxidant properties , 2015, Journal of Physiology and Biochemistry.

[16]  M. Bouaziz,et al.  Lipophilization of ascorbic acid: a monolayer study and biological and antileishmanial activities. , 2014, Journal of agricultural and food chemistry.

[17]  H. K. Vivek,et al.  Ascorbic acid 6‐palmitate: a potent inhibitor of human and soybean lipoxygenase‐dependent lipid peroxidation , 2014, The Journal of pharmacy and pharmacology.

[18]  Om Silakari,et al.  Multifunctional compounds: smart molecules for multifactorial diseases. , 2014, European journal of medicinal chemistry.

[19]  J. Medina-Franco,et al.  Shifting from the single to the multitarget paradigm in drug discovery. , 2013, Drug discovery today.

[20]  J. Cullen,et al.  Ascorbic acid: chemistry, biology and the treatment of cancer. , 2012, Biochimica et biophysica acta.

[21]  Li-Xia Yuwen,et al.  Kinetic biosynthesis of l-ascorbyl acetate by immobilized Thermomyces lanuginosus lipase (Lipozyme TLIM) , 2011, Bioprocess and biosystems engineering.

[22]  M. Decker.  Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond. , 2011, Current medicinal chemistry.

[23]  Riyaz Mohamed,et al.  Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity , 2010, Molecular and Cellular Biochemistry.

[24]  B. Patil,et al.  Bioactive compounds: historical perspectives, opportunities, and challenges. , 2009, Journal of agricultural and food chemistry.

[25]  A. Buschauer,et al.  Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases. , 2006, Bioorganic & medicinal chemistry letters.

[26]  R. Prior,et al.  Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. , 2005, Journal of agricultural and food chemistry.

[27]  Dejian Huang,et al.  The chemistry behind antioxidant capacity assays. , 2005, Journal of agricultural and food chemistry.

[28]  B. Stockwell,et al.  Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.

[29]  S. Chandrasekhar,et al.  Natural product hybrids as new leads for drug discovery. , 2003, Angewandte Chemie.

[30]  H. Nishino,et al.  Inhibitory effects of 6-O-acylated L-ascorbic acids possessing a straight- or branched-acyl chain on Epstein-Barr virus activation. , 2001, Cancer letters.

[31]  H. Baltrusch,et al.  [Strategies for the synthesis of nifedipine analog esters of l-ascorbic acid]. , 2001, Pharmazie.

[32]  S. Yoshida,et al.  Taurospongin A, a Novel Acetylenic Fatty Acid Derivative Inhibiting DNA Polymerase β and HIV Reverse Transcriptase from Sponge Hippospongia sp. , 1997 .

[33]  Y. Doi,et al.  Nuclear magnetic resonance studies on poly(β-hydroxybutyrate) and a copolyester of β-hydroxybutyrate and β-hydroxyvalerate isolated from Alcaligenes eutrophus H16 , 1986 .

[34]  K. Maruyama,et al.  Allylic organometallic way to control acyclic stereochemistry and its application to the synthesis of carbohydrates , 1985 .

[35]  P. Hodge,et al.  Protective groups in organic synthesis , 1981 .